Maurizio Fava
0000-0002-4635-0458
Publication & Citation Trends
Publications
1,217 total
PPA_A_202173 1037..1050
Cited by 0
Semantic Scholar
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) PDF
Cited by 433
OpenAlex
Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses PDF
Cited by 439
OpenAlex
Impact de l’ixékizumab sur les symptômes dépressifs : analyse intégrée de 3 études de phase 3 chez des patients atteints de psoriasis modéré à sévère
Cited by 1
Semantic Scholar
Illness Progression, Recent Stress, and Morphometry of Hippocampal Subfields and Medial Prefrontal Cortex in Major Depression PDF
Cited by 334
OpenAlex
Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study
Cited by 372
OpenAlex
Brain Reactivity to Smoking Cues Prior to Smoking Cessation Predicts Ability to Maintain Tobacco Abstinence PDF
Cited by 420
OpenAlex
Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report PDF
Cited by 441
OpenAlex
Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD
Cited by 376
OpenAlex
Thérapie par combinaison pour la dépression
Cited by 0
Semantic Scholar
Research Topics
Treatment of Major Depression
(583)
Mental Health Research Topics
(215)
Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
(210)
Tryptophan and brain disorders
(164)
Functional Brain Connectivity Studies
(118)
Affiliations
Broad Institute
Sprint (United States)
Boston University
Northwestern University
University of North Carolina at Chapel Hill